‐ Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg). ‐ This anti-diabetic medication will be marketed under brand name LOBG....
Glenmark becomes the first company in the world to launch Ryaltris®-AZ as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg....